Home › Urologic Cancer
Urologic Cancer clinical trials recruiting in the U.S.
9 studies for Urologic Cancer are recruiting participants at sites across the United States.
Cities with the most studies
- Boston, MA5 studies
- Nashville, TN4 studies
- Houston, TX4 studies
- New York City, NY4 studies
- Los Angeles, CA3 studies
- St. Louis, MO3 studies
- Indianapolis, IN3 studies
- Chicago, IL3 studies
- Durham, NC3 studies
By state
- California5 studies
- Illinois4 studies
- Indiana4 studies
- Maryland3 studies
- Massachusetts5 studies
- Michigan4 studies
- Missouri4 studies
- New York4 studies
- North Carolina3 studies
- Ohio4 studies
- Tennessee4 studies
- Texas5 studies
Recently updated studies
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
RecruitingPhase 1
Ages 12 to 50 · All sexes · Updated Nov 10, 2026 · NCT03093909A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06465069FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05614739Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07566156Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 120 · All sexes · Updated Oct 16, 2026 · NCT02379429Urologic Lymphadenectomy in AMIGO
Recruiting
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT05132283uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05874921Vaginal Dilator Therapy After Pelvic Radiation
Recruiting
Ages 18 and older · Women · Updated Jul 22, 2026 · NCT07216456Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
Recruiting
Ages 18 and older · All sexes · Updated Aug 14, 2025 · NCT04442724From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.